HJF Medical Research International

Along the dirt roads deep inside Bar Agulu Village in Siaya County, freshly plowed farms are ready for planting season during the March to June rainy season. Several mango trees can be seen in almost every grass thatched or semi-permanent house within the homesteads. At one of the homesteads, six caregivers and seven children have their morning snack, porridge, under a blend of shade from a house and a mango tree. This is Uhuru Positive Deviance Hearth (PD Hearth), a 12-day community-based behavior change program aimed at rehabilitating underweight and moderately malnourished children.

HJFMRI efforts help bolster local laboratory capability and develop the next generation of scientists to ensure the success of collaborative surveillance research in Kisumu, Kenya.

HJFMRI recently took part in the 15th KEMRI Annual Scientific and Health (KASH) Conference between February 11-15 in Nairobi, Kenya. This year's conference was grounded on the theme of Research Technology and Innovation for Sustainable Health Systems: a Community Driven Agenda.

The CHAMPS data to action program team paves way to improvements for safer labor and delivery at JOOTRH hospital in Kisimu, Kenya.

The CHAMPS data to action program team conducted training for neonatal intensive care nurses on antenatal care approaches to improve outcomes for newborns.

In a significant advancement for Nigeria's public health infrastructure, the TB Modular Laboratory, located at the Defence Reference Laboratory in Mogadishu Cantonment, Abuja, was officially commissioned on August 20, 2024. This state-of-the-art facility represents a new chapter in the fight against tuberculosis (TB) in Nigeria, further strengthening the ongoing partnership between Nigeria and the United States in advancing health outcomes across the nation.

HJFMRI in collaboration with the Tanzania Peoples Defence Forces (TPDF) recently launched the Health Information System (HIS) across 21 supported health facilities within the TPDF. 

Participants at HJF Medical Research International in Abuja, Nigeria, have been vaccinated in the first Phase 2 clinical trial of a Lassa fever virus (LASV) vaccine candidate to date, according to IAVI, a nonprofit scientific research organization and the trial sponsor. 

Geoffrey Mwakyusa (49), a resident of the Kyela District Council in the Mbeya Region, is among hundreds of thousands of people in the area who have connected with Community-based HIV Service Providers (CBHSP) to find out their HIV status through the distribution of HIV self-testing kits.